Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-07

FDA Approved: LAMIVUDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for lamivudine from Ingenus Pharmaceuticals, LLC, confirming authorization for a lamivudine product under the ANDA pathw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)